Main image for the category Allied Health Practitioners

About Collatamp G

Besides the current methods of prevention—proper systemic antibiotic use, skin preparation and surgical techniques—there is now another way to dramatically reduce surgical site infections in your patients.

For over 20 years, Collatamp G has been used in two million patients across the globe to reduce the risk of and treat surgical site infection.

Collatamp G is now available in Canada.

What Is Collatamp G?

Collatamp G is a lyophilized collagen sponge impregnated with the aminoglycoside antibiotic gentamicin that gives you the ability to reduce the rate of surgical site infections 50-85%.

Collatamp G delivers and maintains a high concentration of drugs directly at the surgical site, killing bacteria that may be antibiotic-resistant at lower doses, such as those achieved by systemic antibiotic prophylaxis alone.

And with no risk of systemic toxicity and no reported side effects, Collatamp G is a strong, effective adjunct to the lower-dose prophylactic antibiotic protocols that are already used at your hospital.

Advantages of a Collagen-Based Drug Delivery System

Many device-drug combination products—pumps for continuous infusion of local anesthetics, medicated stents and bone cements carrying an antibiotic—work well as localized delivery systems.

Collagen, however, has the advantage of being a natural and well-established biocompatible material, with proven wound-healing and haemostatic properties.

Collatamp G safely delivers the appropriate dosage of gentamicin through a combination of diffusion and natural enzymatic breakdown of the collagen matrix.

This provides both rapid and prolonged release, which has been mathematically modelled.

A Powerful, Cost-Effective Method of Reducing the Risk of Surgical Site Infections

With Collatamp G, you'll not only provide better care for your patients while improving patient safety and surgical outcomes—you'll also save your hospital money.

At $4,000 per patient, surgical site infections cost the Canadian healthcare system over $200 million each year.

By simply using Collatamp G on high-risk surgical patients, you can reduce healthcare costs for surgical site infections by at least 25%.

And Collatamp G can deliver these savings for less than half of 1% of your operating room budget.

Interested in Learning More?

Find out how your hospital can start using Collatamp G to reduce surgical site infections.

About Surgical Site Infections

Preventing Surgical Site Infections